Dotmatics: Instant Antibody Drug Conjugate MS Data analysis at PEGS 2014 - Applied Clinical Trials

ADVERTISEMENT

See our 2013 Buyers Guide Digital Edition.
Dotmatics: Instant Antibody Drug Conjugate MS Data analysis at PEGS 2014


Dotmatics: Instant Antibody Drug Conjugate MS Data analysis at PEGS 2014

PR Newswire

BISHOPS STORTFORD, England, May 7, 2014 /PRNewswire/ --

Meet Dotmatics at booth #127 to analyse and visualise antibody and drug mass  


Dotmatics, a leading provider of scientific informatics solutions and services to the pharmaceutical and biotechnology industries, will be exhibiting at booth #127 of the 10th Annual PEGS Boston conference at the Seaport World Trade Center from May 5 th - 9th.

Dotmatics' new Antibody Drug Conjugate (ADC) module can instantly load mass spectrometry (MS) spectra and identify and label the main conjugation species, including undesired side-reaction conjugates. Users can simply import raw MS data or converted data files and peaks are automatically identified. In addition, scientists can easily analyse kinetics and coupling reactions over time. This eliminates the hours of tedious analysis that is currently required thus making the whole process faster and more efficient.

Web-based solution Bioregister from Dotmatics enables the easy registration of biological entities and management of data associated with their production including protein expression, purification and characterisation. Throughout PEGS Boston, Dotmatics' Application Scientists will be available to discuss and demonstrate the ways in which Bioregister meets the needs of protein scientists who are looking for an easy way to keep track of sequence information and any batches of protein produced for those sequences.

Dotmatics will also showcase long established enterprise solutions including revolutionary data analysis and visualisation tool Vortex, query and reporting tool, Browser and Studies Notebook which fully integrates with Bioregister providing biologists with complete informatics coverage of their laboratory workflow.

About Dotmatics:  

Dotmatics is a leading global scientific informatics software and services provider, delivering solutions tailored to the modern, highly collaborative and mobile scientific environments. The company provides solutions to several vertical markets, including the pharmaceutical, biotechnology, academia, food and beverage, oil and gas and agrochemical industries. Dotmatics' enterprise solutions are flexible, scalable and configurable, providing effective scientific information management across entire organisations, from discovery research to development and early manufacturing. Dotmatics has significant expertise in scientific informatics, including database management for chemistry and biologics, electronic laboratory notebooks, chemical and biological registration, screening data management, SAR analysis, reporting, and visualisation. Dotmatics solutions are available for local or cloud deployment and they are supported on Microsoft Windows, Mac OS X and Linux.  A privately owned company, Dotmatics was founded in 2005 and their headquarters is based south of Cambridge in the UK.

Enquiries:
Dr Shikha O'Brien
Dotmatics Limited
Tel (Europe): +44(0)1279 654 123
Tel (US West Coast): +1(619)419-2808
Tel (US East Coast): +1(781)281-2330
Fax: +44(0)1279-653-088
Email: info@dotmatics.com
Website: http://www.dotmatics.com

SOURCE Dotmatics

ADVERTISEMENT

blog comments powered by Disqus

ADVERTISEMENT

Survey
As it creates a plan to implement the US biosimilar pathway, should FDA:
Borrow heavily from EMA's pathway program?
Borrow lightly from EMA's pathway program?
Create entirely its own pathway program?
Borrow heavily from EMA's pathway program?
87%
Borrow lightly from EMA's pathway program?
6%
Create entirely its own pathway program?
8%
View Results
Untitled Document

Click here